nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—GALR3—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.0926	0.0926	CbGpPWpGaD
Ritodrine—GALR3—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.0712	0.0712	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.0435	0.0435	CbGpPWpGaD
Ritodrine—GALR3—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.0367	0.0367	CbGpPWpGaD
Ritodrine—GALR3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0341	0.0341	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.0335	0.0335	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	0.0322	0.0322	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—AGTR1—focal segmental glomerulosclerosis	0.0295	0.0295	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0292	0.0292	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.0284	0.0284	CbGpPWpGaD
Ritodrine—GALR3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.0262	0.0262	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.0236	0.0236	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—AGTR1—focal segmental glomerulosclerosis	0.0233	0.0233	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0225	0.0225	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.0222	0.0222	CbGpPWpGaD
Ritodrine—GALR3—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.0199	0.0199	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.019	0.019	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0171	0.0171	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.0158	0.0158	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.0145	0.0145	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0126	0.0126	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0126	0.0126	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.012	0.012	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0119	0.0119	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0115	0.0115	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0114	0.0114	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0109	0.0109	CbGpPWpGaD
Ritodrine—PGD—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.0108	0.0108	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0106	0.0106	CbGpPWpGaD
Ritodrine—ADRB2—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.0101	0.0101	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00966	0.00966	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00959	0.00959	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00922	0.00922	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00878	0.00878	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00819	0.00819	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00776	0.00776	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00744	0.00744	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0068	0.0068	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00678	0.00678	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00674	0.00674	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00665	0.00665	CbGpPWpGaD
Ritodrine—PGD—Metabolism—LIPC—focal segmental glomerulosclerosis	0.0064	0.0064	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00617	0.00617	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00597	0.00597	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00567	0.00567	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00564	0.00564	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.0052	0.0052	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00518	0.00518	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00511	0.00511	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00506	0.00506	CbGpPWpGaD
Ritodrine—PGD—Disease—LPL—focal segmental glomerulosclerosis	0.00467	0.00467	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00439	0.00439	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00433	0.00433	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00426	0.00426	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00404	0.00404	CbGpPWpGaD
Ritodrine—PGD—Metabolism—LPL—focal segmental glomerulosclerosis	0.00391	0.00391	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00389	0.00389	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00365	0.00365	CbGpPWpGaD
Ritodrine—PGD—Disease—NOS2—focal segmental glomerulosclerosis	0.00365	0.00365	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.0036	0.0036	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00337	0.00337	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AGT—focal segmental glomerulosclerosis	0.00334	0.00334	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.0033	0.0033	CbGpPWpGaD
Ritodrine—PGD—Disease—SERPINE1—focal segmental glomerulosclerosis	0.00307	0.00307	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00288	0.00288	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00286	0.00286	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.0028	0.0028	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00274	0.00274	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0027	0.0027	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00261	0.00261	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0026	0.0026	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ALB—focal segmental glomerulosclerosis	0.00257	0.00257	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00248	0.00248	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0022	0.0022	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00215	0.00215	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.002	0.002	CbGpPWpGaD
Ritodrine—PGD—Disease—TGFB1—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00177	0.00177	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00153	0.00153	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.001	0.001	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000971	0.000971	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000919	0.000919	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00083	0.00083	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000767	0.000767	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000638	0.000638	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000489	0.000489	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000403	0.000403	CbGpPWpGaD
